Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Feb 13, 2012  |  BioCentury | Emerging Company Profile

Abide: Selecting serine hydrolases

million Investors: Cardinal Partners CEO: Alan Ezekowitz Patents: 10 issued covering MAGL , FAAH , arylacetamide deacetylase-like 1
12:00 AM, May 05, 2011  |  BC Innovations | Distillery Therapeutics

Indication: Cancer

week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Arylacetamide deacetylase-like 1